# Hyperbaric Oxygen as an Adjuvant Treatment for Patients With Covid-19 Severe Hypoxemia

> **NCT04477954** · PHASE2 · TERMINATED · sponsor: **Asociación Argentina de Medicina Hiperbárica e Investigación** · enrollment: 40 (actual)

## Conditions studied

- Covid19

## Interventions

- **COMBINATION_PRODUCT:** Hyperbaric Oxygen

## Key facts

- **NCT ID:** NCT04477954
- **Lead sponsor:** Asociación Argentina de Medicina Hiperbárica e Investigación
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-07-06
- **Primary completion:** 2020-11-06
- **Final completion:** 2020-12-30
- **Target enrollment:** 40 (ACTUAL)
- **Why stopped:** Investigators and Ethic Committee endorsed early suspension of the protocol because of superiority and safety. For the interim analysys, the statistical methodology presented by Pocock was followed.
- **Last updated:** 2021-01-15

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04477954

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04477954, "Hyperbaric Oxygen as an Adjuvant Treatment for Patients With Covid-19 Severe Hypoxemia". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04477954. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*